Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Several Options Remain For Cidara’s Flu Candidate After J&J Halts Development
Jul 21 2023
•
By
Ayisha Sharma
Janssen Could Out-License The Asset Or Return It To Cidara • Source: Shutterstock
More from Business
More from Scrip